BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife Pharma (CSE:BETR) initiates preclinical study against Delta variant

BetterLife Pharma (BETR) has initiated a preclinical study of AP-003 (rhIFNa2b) against the Delta variant of SARS-CoV-2.
Sixth Wave Innovations - President and CEO, Dr. Jon Gluckman (left).

" Sixth Wave Innovations’ (CSE:SIXW) AMIPs technology detects Delta variant

Sixth Wave’s (SIXW) accelerated molecular imprinted polymers (AMIPs) technology has detected the Delta variant of SARS-CoV-2.